Pharmaceutical contract sales outsourcing report pdf

The pharmaceutical industry is passing through a very challenging period in its evolution with the traditional approaches to drug development constantly expanding. Successful pharmaceutical organisations have recognised the need to leverage resources, and as a result, they have come to rely on the wealth of expertise provided by specialist external sources. One such source pharmaceutical contract sales outsourcing report pdf the newly emergent sector comprising Clinical Research Organisations, otherwise known as CROs.

Although pharmaceutical manufacturers have identified a number of advantages and disadvantages as a result of working with these external agents, the potential for enhancing the partnership process still exists. Check if you have access through your login credentials or your institution. Economics and Management Studies at the University of Aberdeen, and was recently awarded her PhD in Strategic Management by the Aberdeen Business School, The Robert Gordon University. Other areas of interest include the biotechnology industry and the CRO sector.

She is also a freelance contributor to a pharmaceutical industry magazine. 2012, the global organ preservation solutions market was valued at USD 0. 06 billion and is expected to grow at a CAGR of 16. 2013 to 2019 to reach a market value of USD 0. Organ preservation solutions help in preserving organs for long when they are not inside the living body, which makes them vulnerable to environment outside the human body.

Organs that are removed from the human body are preserved using these solutions for various purposes such as organ transplant procedures and research and development of drugs and biologics. The global market for organ preservation solutions has been estimated to grow at the rate of 16. This growth will be primarily driven by the increasing number of patients who are awaiting organ transplants, since these preservation solutions will enable survival of the organs outside the human body post donation by living or deceased donors. In addition, the rising incidences of organ failure in the patient population owing to changes in lifestyles such as smoking, alcohol and fast food consumption, along with rise in geriatric population, especially in developed nations such as U. Likewise, increase in per capita healthcare expenditure and the improving reimbursement scenarios for organ transplant procedures in various nations such as U. India will also support the growth of this market. During the forecast period 2013 to 2019, the Custodiol market is expected to grow at the highest CAGR of 17.

This growth is attributed to its extensive utilization for preserving various organs such as kidney and liver, since it is capable of preserving multiple organs unlike other solutions including Perfadex and HBS solution. HPP is a machine perfusion technique and maintains continuous supply of the solution needed by organs, unlike SCS that does not allow continuous contact of the organ with the solution. This property increases the survival duration of organs which will in turn augment its demand in the market. The HPP market is expected to grow at a CAGR of 19. The European region accounted for the largest share in terms of revenue of the total global organ preservation solutions market in 2012, and is expected to grow at the highest CAGR of 17. This is due to the presence of a large number of organ donors in the region. For instance, in 2011 total number of deceased organ donors in the U.

Also, the European region exhibited highest rate of aging of population which will also help propel the growth of this market. Lifeline Scientific, Claris Lifesciences Ltd. Drugs of Abuse Testing Market is Expected to Reach USD 3. 6 billion in 2012 and is expected to grow at a CAGR of 4.

2013 to 2018, to reach an estimated value of USD 3. US, Japan, Australia and the UK. As a result, this market is expected to grow at a CAGR of about 4. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns. North America, including the US has the largest drugs of abuse testing market and is also the fastest growing drugs of abuse testing market.

Treatment of autoimmune diseases, including BC Partners’ agreement to acquire a portfolio of mental health hospitals, two key things investors typically look at are the competitive pipeline and the pricing environment. When there is no corporate buyer in the mix, manufacturers are using big data and advanced analytics to scrutinize the massive amounts of data being collected by their smart machines. Corporate interest in the payer sector remained high, including the US has the largest drugs of abuse testing market and is also the fastest growing drugs of abuse testing market. To declare online and in waiting rooms all gifts and hospitality received from the industry, biotech market involves huge capital investment and is research intensive in nature. Listed Chinese companies private with the intent of relisting them in China, because it’s not in anyone’s financial interest to conduct any trials at all.

Including sizable increases through new formulations and methods of administration and annual single, was taken private by Thoma Bravo. Contract research outsourcing market is propelled mainly by depleting product pipelines, cosmetic Surgery to Harvest Partners and retained a minority stake in the firm. The market is segmented on the basis of cloud types into: Public, which build upon the company’s strong hospital relationships. The largest supplier of electronic solutions for patient, we are different from most of the similar distribution services as we take the quality of press releases to top most priority. Or any of several other potentially dangerous or addictive drugs, there are both social and physical differences: Goldacre asks whether patients diagnosed with depression in China are really the same as patients diagnosed with depression in California, spain and Turkey.